SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline

Nav

General Info

Provider

National Center for Biotechnology Information, United States National Library of Medicine

Tabulations only

Geography

Canada (CAN)

Ontario

Coverage type

Subnational

Time period covered

03/2020 - 08/2020

Data type

Scientific literature

Keywords

Blood tests, COVID-19, Disease outbreaks, Infectious diseases, Medical tests

Citation

Authors

Bolotin S, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, Allen VG

Journal

J Infect Dis

Volume

223

Issue

Pages

1334-1338

Publication year

2021

Suggested citation

Bolotin S, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, Allen VG. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. J Infect Dis. 2021; 223(8): 1334-1338.

DOI

10.1093/infdis/jiaa796

PMID

33400794

GHDx Entry last modified on: May 12, 2022

Header sites

Search form

Main menu

SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline

Nav